47.30
price up icon2.60%   1.20
after-market Handel nachbörslich: 47.30
loading

Palvella Therapeutics Inc Aktie (PVLA) Neueste Nachrichten

pulisher
Aug 16, 2025

Palvella Therapeutics Inc. stock momentum explainedEarnings Recap Summary & Short-Term Swing Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Truist Financial Maintains Palvella Therapeutics(PVLA.US) With Buy Rating - 富途牛牛

Aug 16, 2025
pulisher
Aug 16, 2025

What institutional flow reveals about Palvella Therapeutics Inc.Earnings Summary Report & AI Enhanced Trading Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Palvella Therapeutics Inc. stock trend forecast2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Exit strategy if you’re trapped in Palvella Therapeutics Inc.Index Update & Safe Entry Zone Tips - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

What makes Palvella Therapeutics Inc. stock price move sharplyWeekly Trend Report & Low Drawdown Momentum Ideas - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Palvella Completes Enrollment in Phase 3 SELVA Trial - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

What indicators show strength in Palvella Therapeutics Inc.Trade Ideas & Low Risk Investment Opportunities - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

How to read the order book for Palvella Therapeutics Inc.July 2025 Selloffs & Weekly Momentum Picks - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Ranking Palvella Therapeutics Inc. among high performing stocks via toolsMarket Activity Recap & Accurate Technical Buy Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Visual trend scoring systems applied to Palvella Therapeutics Inc.Portfolio Value Summary & Short-Term Swing Trade Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Will Palvella Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsTake Profit & Intraday High Probability Setup Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Palvella Therapeutics: Q2 Earnings Snapshot - Norwalk Hour

Aug 15, 2025
pulisher
Aug 15, 2025

Risk vs reward if holding onto Palvella Therapeutics Inc.Weekly Profit Report & Low Drawdown Investment Ideas - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Palvella Therapeutics Advances Rare Disease Pipeline - TipRanks

Aug 15, 2025
pulisher
Aug 14, 2025

Palvella Therapeutics price target raised to $60 from $45 at Stifel - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

Palvella Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: Palvella Therapeutics Q2 2025 shows stock decline - Investing.com

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: Palvella Therapeutics Q2 2025 shows stock decline By Investing.com - Investing.com Nigeria

Aug 14, 2025
pulisher
Aug 14, 2025

Palvella Q2 2025 slides: Strong pipeline progress, shares fall in premarket trading - Investing.com Canada

Aug 14, 2025
pulisher
Aug 14, 2025

Palvella Therapeutics (PVLA) Q2 2025 Earnings: Why the Loss Matters Less Than the Phase 3 Trial Momentum - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Palvella Posts Cash Gain and Trial Wins - Nasdaq

Aug 14, 2025
pulisher
Aug 14, 2025

Palvella's Skin Disease Drug Shows Promise with 25% Over-Enrolled Phase 3 Trial, Two Key Readouts Ahead - Stock Titan

Aug 14, 2025
pulisher
Aug 13, 2025

Will Palvella Therapeutics Inc. stock recover after recent dropMarket Volume Report & Safe Swing Trade Setups - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Palvella Therapeutics Inc. stock volume spike explainedJuly 2025 Outlook & Safe Capital Preservation Plans - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Is Palvella Therapeutics Inc. forming a reversal patternSwing Candidate List with Trade Cues - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Is Palvella Therapeutics Inc. stock entering bullish territorySecure Buy Strategy Based on Risk Parameters - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

How hedge fund analytics apply to Palvella Therapeutics Inc. stockFree Stock Selection With High Accuracy - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Palvella Therapeutics CEO to Speak at Canaccord Genuity Growth Conference - MSN

Aug 12, 2025
pulisher
Aug 12, 2025

Palvella Therapeutics (PVLA) to Release Earnings on Thursday - Defense World

Aug 12, 2025
pulisher
Aug 11, 2025

Detecting price anomalies in Palvella Therapeutics Inc. with AIFree Daily Chart Pattern Stock Forecast - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Palvella Therapeutics to Report Q2 Financials and Corporate Update on August 14 - MSN

Aug 10, 2025
pulisher
Aug 10, 2025

Will Palvella Therapeutics Inc. price bounce be sustainableInvestment Life Cycle Planning Summary - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

How Palvella Therapeutics Inc. stock performs during market volatilityAsset Allocation Summary With Future Outlook - Newser

Aug 10, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):